Serum Levels of Advanced Oxidation Protein Products and some Liver Function Markers in Chronic Myeloid Leukemia-Chronic Phase Patients Receiving Imatinib or Nilotinib

The treatment of chronic myeloid leukemia has witnessed substantial advancements by the introduction of tyrosine kinase inhibitors. Oxidative stress has been proposed as potential mechanism for resistance to their action. Simultaneously, oxidative stress has a crucial role in hepatic diseases and h...

Full description

Bibliographic Details

Published in:	Iraqi Journal of Pharmaceutical Sciences
Main Authors:	Ikhlas Khammas, Ali Abdulhussain Kasim, Bassam Francis
Format:	Article
Language:	English
Published:	College of Pharmacy University of Baghdad 2025-06-01
Subjects:	Chronic myloid leukemia imatinib nilotinib Oxidative stress
Online Access:	https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2932